• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋肉碱对重型和中间型β地中海贫血患者超声心动图变化的影响

The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.

作者信息

Shahidi Mohsen, Hashemi Sayedeh Rozhin, Fattahi Nima, Roshani Daem, Vahedi Siamak, Sharifi Pezhman, Moradveisi Borhan

机构信息

Department of Cardiology, Besat Hospital.

Faculty of Medicine.

出版信息

J Pediatr Hematol Oncol. 2020 Aug;42(6):386-390. doi: 10.1097/MPH.0000000000001850.

DOI:10.1097/MPH.0000000000001850
PMID:32555029
Abstract

INTRODUCTION

Heart failure, fatal arrhythmias, and cardiac dilatation because of anemia are common causes of β-thalassemia major-related deaths. The aim of this study was to determine the effect of L-carnitine on echocardiographic changes in β-thalassemia major and intermedia patients in Besat Hospital in Sanandaj, Iran.

METHODS

In a randomized clinical trial, 60 β-thalassemia patients who were eligible for L-carnitine administration were randomly divided into 2 placebo and study drug groups. The duration of the study was 6 months. Using echocardiography and blood tests, cardiac parameters including left ventricular dilatation, left ventricular hypertrophy, and a number of cardiac blood indices were examined before and after the intervention. The data were analyzed using SPSS V.23 software, χ, and covariance statistical tests.

RESULTS

There was no significant difference between the 2 groups in terms of age and sex. Patients treated with L-carnitine have a reduced rate of left ventricular dilatation, left ventricular hypertrophy, and systolic blood pressure compared with controls (P<0.05). Cardiac output increased from 43.5 to 56.5 (P=0.002).

CONCLUSIONS

The results of this study showed that the drug has a positive effect on the improvement of cardiac indices in β-thalassemia patients. Therefore, we suggest that further studies with more samples and other diagnostic modalities of the drug's effect be investigated.

摘要

引言

心力衰竭、致命性心律失常以及因贫血导致的心脏扩张是重型β地中海贫血相关死亡的常见原因。本研究的目的是确定左旋肉碱对伊朗萨南达杰贝萨特医院重型和中间型β地中海贫血患者超声心动图变化的影响。

方法

在一项随机临床试验中,60名符合左旋肉碱给药条件的β地中海贫血患者被随机分为2个安慰剂组和研究药物组。研究持续时间为6个月。使用超声心动图和血液检测,在干预前后检查包括左心室扩张、左心室肥厚以及一些心脏血液指标在内的心脏参数。数据使用SPSS V.23软件、χ检验和协方差统计检验进行分析。

结果

两组在年龄和性别方面无显著差异。与对照组相比,接受左旋肉碱治疗的患者左心室扩张、左心室肥厚和收缩压的发生率降低(P<0.05)。心输出量从43.5增加到56.5(P=0.002)。

结论

本研究结果表明该药物对改善β地中海贫血患者的心脏指标有积极作用。因此,我们建议对该药物作用进行更多样本和其他诊断方式的进一步研究。

相似文献

1
The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.左旋肉碱对重型和中间型β地中海贫血患者超声心动图变化的影响
J Pediatr Hematol Oncol. 2020 Aug;42(6):386-390. doi: 10.1097/MPH.0000000000001850.
2
Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia.羟基脲联合左卡尼汀和氯化镁治疗中间型β地中海贫血患者的血液学参数和心功能的影响。
Eur J Haematol. 2010 Jan 1;84(1):52-8. doi: 10.1111/j.1600-0609.2009.01356.x. Epub 2009 Oct 3.
3
Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.重型β地中海贫血中的肺动脉高压及左旋肉碱治疗的作用。
Pediatr Hematol Oncol. 2008 Dec;25(8):734-43. doi: 10.1080/08880010802244035.
4
Improvement of cardiac function in thalassemia major treated with L-carnitine.左旋肉碱治疗重型地中海贫血患者心脏功能的改善
Acta Haematol. 2004;111(3):143-8. doi: 10.1159/000076522.
5
Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.中间型和重型β地中海贫血的超声心动图表现:中间型β地中海贫血患者经羟基脲治疗后无肺动脉高压
Eur J Haematol. 2009 Mar;82(3):213-8. doi: 10.1111/j.1600-0609.2008.01192.x. Epub 2008 Dec 5.
6
A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.中间型β地中海贫血和重型β地中海贫血临床无症状患者的心功能与心律失常比较
Hematology. 2017 Jan;22(1):25-29. doi: 10.1080/10245332.2016.1226699. Epub 2016 Sep 20.
7
Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.埃及中间型β地中海贫血和重型β地中海贫血患者的临床病理与放射学研究:与并发症及治疗反应的关系
Hemoglobin. 2011;35(4):382-405. doi: 10.3109/03630269.2011.598985.
8
Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.左旋肉碱给药对急性前壁心肌梗死后左心室重构的影响:左旋肉碱数字化超声心动图心肌梗死(CEDIM)试验
J Am Coll Cardiol. 1995 Aug;26(2):380-7. doi: 10.1016/0735-1097(95)80010-e.
9
L-Carnitine treatment in beta thalassemia major.
Acta Haematol. 1998 Dec;100(3):162-3. doi: 10.1159/000040895.
10
Left ventricular diastolic abnormalities in children with beta-thalassemia major: a Doppler echocardiographic study.重型β地中海贫血患儿的左心室舒张功能异常:一项多普勒超声心动图研究。
Turk J Pediatr. 1998 Apr-Jun;40(2):201-9.

引用本文的文献

1
Nutritional studies in patients with β-thalassemia major: A short review.β-重型地中海贫血患者的营养研究:简要综述。
Acta Biomed. 2023 Jun 14;94(3):e2023187. doi: 10.23750/abm.v94i3.14732.
2
Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest.肥胖背景下的氧化应激与血管损伤:隐藏的因素
Antioxidants (Basel). 2021 Mar 8;10(3):406. doi: 10.3390/antiox10030406.